Determination of MK-0767 enantiomers in human plasma by normal phase LC-MS/MS.
A sensitive and selective analytical method for the enantioselective determination of MK-0767, a dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist, in human plasma has been developed and validated. The chromatography is based on normal-phase chiral separation on a Kromasil, 5 microm, CHI-DMB 250 mm x 4.6 mm column. The detection involves the direct introduction of the normal phase eluent into MS/MS without the addition of a post-column reagent. Atmospheric pressure chemical ionization (APcI) mode was selected as the ion source in this method. With proper sample handling and processing procedures, ex vivo interconversion of the enantiomers was kept to minimum during sample collection, preparation and short term storage of frozen human plasma samples. The method was successfully utilized to determine the concentrations of MK-0767 enantiomers in human plasma to support pharmacokinetic investigation in man.
Yan
Kerri X
KX
Department of Drug Metabolism, Merck Research Laboratories, WP75A-303, West Point, PA-19486, USA. Kerri-Yan@merck.com
Song
Hengchang
H
Lo
Man-Wai
MW
D002853:Chromatography, Liquid / Q000379:methods*; D006801:Humans; D013058:Mass Spectrometry / Q000379:methods*; D012015:Reference Standards; D012680:Sensitivity and Specificity; D013237:Stereoisomerism; D013844:Thiazoles / Q000097:blood* / Q000493:pharmacokinetics
C487303:MK0767; D013844:Thiazoles